Related Experiment Video
Updated: Aug 11, 2026
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Langerhans cell sarcoma
Tammie Ferringer1, Peter M Banks, John S Metcalf
1Medical University of South Carolina, Charleston, SC 29425, USA.
Insights
This study details a rare case of malignant Langerhans cell sarcoma in a 33-year-old male. The tumor showed aberrant CD31 expression, potentially influencing its spread to lymph nodes.
Area of Science:
- Oncology
- Pathology
- Immunohistochemistry
Background:
- Langerhans cell proliferations are histologically classified into benign Langerhans cell histiocytosis and malignant Langerhans cell sarcoma.
- Understanding the distinct biological behaviors of these conditions is crucial for accurate diagnosis and treatment.
Observation:
- A case of Langerhans cell sarcoma was identified in a 33-year-old male.
- The sarcoma originated on the posterior thigh and involved regional lymph nodes.
Findings:
- Microscopic, immunohistochemical, and ultrastructural analyses confirmed Langerhans cell differentiation.
- Aberrant CD31 expression was noted, a feature also seen in Langerhans cell histiocytosis.
- This aberrant expression may contribute to the tumor's migratory potential.
Implications:
- This case expands the understanding of Langerhans cell sarcoma presentation and behavior.
- Aberrant CD31 expression in Langerhans cell neoplasms warrants further investigation for its role in tumor cell migration and metastasis.
Abstract:
Proliferations of Langerhans cells can be histologically divided into cytologically benign Langerhans cell proliferations, which include the clinical syndromes of Langerhans cell histiocytosis, and cytologically malignant Langerhans cell sarcoma. We report a Langerhans cell sarcoma in a 33-year-old male that arose on the posterior thigh with subsequent regional lymph node involvement. Conventional microscopic, immunohistochemical, and ultrastructural analysis confirmed Langerhans cell differentiation. Aberrant CD31 expression, similar to that described previously in Langerhans cell histiocytosis, was prominent in this tumor, possibly enhancing its migratory capabilities.
